Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Active, not recruiting · NCT03049189 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 3 | 2026-08-07 | NCT03049189 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ABX CRO | 3 |
| ITM Solucin GmbH | 3 |
| PSI CRO | 8 |
52 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.